Hematogenous Methicillin-Resistant Staphylococcus Aureus Spondylodiscitis
- 15 October 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 32 (22) , 2480-2486
Abstract
Study Design. Retrospective case series. Objective. To determine relevant demographics, clinical presentations, and outcomes of this condition. Summary of Background Data. This is the first study looking specifically at methicillin-resistant Staphylococcus Aureus (MRSA) spondylodiscitis. Methods. We performed a retrospective review of patients presenting between 2000 and 2005. Results. Thirteen cases were identified. The mean age was 65 years; 85% were male. All cases presented with back pain, spinal tenderness, and systemic upset. Neurologic deficit was present initially in 39%, and 8% developed neurologic deterioration during treatment. The thoracic spine (53%) was most commonly affected, followed by the lumbar (33%), thoracolumbar junction (7%), and cervical spine (7%); 16% of cases were multilevel. The white cell count, erythrocyte sedimentation rate and C-reactive protein were elevated in all cases with means of 17.3 × 10−9/L, 102 mm/h, and 236 mg/L, respectively. Radiologic diagnosis was established with MRI in all cases. The most common risk factors were diabetes mellitus (62%), malnourishment (54%), cirrhosis (31%), end-stage renal failure (15%), and intravenous drug use (15%). Multiple risk factors were present in 76% of cases, and only 15% had no identifiable risk factors. The main sources of sepsis were intravenous catheters (23%), urinary tract (15%), and intravenous drug use (15%). Treatment consisted of intravenous vancomycin monotherapy for a mean period of 4 weeks followed by oral combination or monotherapy antimicrobials for a mean period of 8 weeks. Operative intervention was required in 38% of cases. At 6 months, 54% of cases were clinically free of infection, 38% had died, and 8% required ongoing treatment. Neurologic deficit was present in 50% of survivors. At 1 year, 29% of survivors had MRSA bacteremia and spondylodiscitis recurrence. Conclusion. This is a devastating condition with high mortality and morbidity.Keywords
This publication has 57 references indexed in Scilit:
- Hematogenous Vertebral Osteomyelitis Due to Staphylococcus aureus in the Adult: Clinical Features and Therapeutic OutcomesSouthern Medical Journal, 2005
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- CorrespondenceThe Journal of Bone and Joint Surgery. British volume, 1997
- MR imaging of vertebral osteomyelitis revisited.American Journal of Roentgenology, 1996
- Nosocomial and Community-Acquired Staphylococcus aureus Bacteremias from 1980 to 1993: Impact of Intravascular Devices and Methicillin ResistanceClinical Infectious Diseases, 1996
- Neurosurgical Management of Thoracic and Lumbar Vertebral Osteomyelitis and Discitis in Adults: A Review of 43 Consecutive Surgically Treated PatientsNeurosurgery, 1996
- Role of MR imaging in the management of spinal infections.American Journal of Roentgenology, 1992
- Diagnosis and management of pyogenic vertebral osteomyelitis in adultsSurgical Neurology, 1990
- Osteomyelitis: The Past DecadeNew England Journal of Medicine, 1980
- Osteomyelitis of the SpineActa Orthopaedica, 1977